Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

Rachel M. Hurley, Cordelia D. McGehee, Ksenija Nesic, Cristina Correia, Taylor M. Weiskittel, Rebecca L. Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M. Pathoulas, X. Wei Meng, Olga Kondrashova, Marc R. Radke, Paula A. Schneider, Karen S. Flatten, Kevin L. Peterson, Marc A. Becker, Ee Ming Wong, Melissa S. Southey, Alexander Dobrovic, Kevin K. LinThomas C. Harding, Iain McNeish, Christian A. Ross, Jill M. Wagner, Matthew J. Wakefield, Clare L. Scott, Paul Haluska, Andrea E.Wahner Hendrickson, Larry M. Karnitz, Elizabeth M. Swisher, Hu Li, S. John Weroha, Scott H. Kaufmann

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences